Cancer funding

    Fort Washington-based National Comprehensive Cancer Network has been awarded a $2.1 million grant.

    The grant from Pfizer will help develop a program to study axitinib in tumors, the Business Journal reports. Axitinib could be linked to the growth and metastatic progression of tumors.


    • WHYY thanks our sponsors — become a WHYY sponsor

    WHYY is your source for fact-based, in-depth journalism and information. As a nonprofit organization, we rely on financial support from readers like you. Please give today.

    Want a digest of WHYY’s programs, events & stories? Sign up for our weekly newsletter.

    Together we can reach 100% of WHYY’s fiscal year goal